Last Price
64.79
Today's Change
+0.48 (0.74%)
Day's Change
51.47 - 66.42
Trading Volume
943,281
Overview
Market Cap
421 Million
Shares Outstanding
6 Million
Avg Volume
185,662
Avg Price (50 Days)
16.09
Avg Price (200 Days)
11.73
PE Ratio
-3.52
EPS
-18.39
Earnings Announcement
11-Nov-2024
Previous Close
64.31
Open
58.02
Day's Range
51.47 - 66.425
Year Range
6.08 - 92.0
Trading Volume
944,539
Price Change Highlight
1 Day Change
0.75%
5 Day Change
118.15%
1 Month Change
544.04%
3 Month Change
548.55%
6 Month Change
422.08%
Ytd Change
733.85%
1 Year Change
655.13%
3 Year Change
-83.61%
5 Year Change
-87.75%
10 Year Change
-87.75%
Max Change
-87.75%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CryptoNews
2
CEO Morning Brief
Trump Unveils Crypto Project, Says US Should Dominate Sector
3
4
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
